Securities Class Action

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$0

Material Events

Critical Governance & Disclosure

4

Board, Voting & Shareholder Rights

11

Capital Structure & Financial Risk

1

Disclosure & Communications

20

SEC Filings

DEF 14A

Other definitive proxy statements

2026-11-05

View DEF 14A Other definitive proxy statements on SEC.gov
DEFA14A

Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-11-05

View DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material on SEC.gov
Form 4

Statement of changes in beneficial ownership of securities

2026-11-04

View Form 4 Statement of changes in beneficial ownership of securities on SEC.gov
Form 4

Statement of changes in beneficial ownership of securities

2026-11-04

View Form 4 Statement of changes in beneficial ownership of securities on SEC.gov
8-K

Current report

2026-11-02

View 8-K Current report on SEC.gov

Insider Transaction

No Insider Transactions found for NRX Pharmaceuticals, Inc.